• Kechao Nie, Zhihua Xing, Wei Huang, Weihao Wang, and Weiping Liu.
• Institute of Integrated Medicine, Xiangya Hospital, Central South University, Changsha, Hunan Province, China - 18692224642@163.com.
• Minerva Med. 2016 Apr 21.

AbstractInconsistent results on the relationship between coffee consumption and pancreatic cancer risk has been reported in both epidemiological studies and previous meta-analyses. This updated meta-analyses was conducted to assess the association of coffee intake with pancreatic cancer risk. We evaluated the relationship of coffee ingestion and pancreatic cancer risk by performing a meta-analysis of prospective cohort studies and made an explicit document search in the PubMed database before November 2015. We also obtained prospective cohort studies of previous meta-analyses. A random-effects model was used for pooling overall relative risk. Twenty articles of coffee ingestion and pancreatic cancer were contained in our meta-analysis. The summary relative risk (RR) of pancreatic cancer and coffee intake of the highest compared with lowest category was 0.99 (95% CI = 0.81-1.21), with statistically moderate heterogeneity (I2 = 47.9%, P = 0.008). The heterogeneity reduced to I2 = 38.5% after excluding one studies, and the RR was 1.06 (95% CI = 0.94-1.20). The relationships of coffee intake and pancreatic risk did not modified by geographic areas, sex of participants, number of cases, follow-up years, and the number of adjusted confounders. Dose-response analysis indicated that every one-cup increase in coffee consumption was associated with an 1% increase in pancreatic cancer risk. No statistically significant publication biases existed. Coffee consumption may weakly increase the risk of pancreatic cancer.

9 keywords...

hide…